Comparative effectiveness and persistence of TNFi and non-TNFi in juvenile idiopathic arthritis: a large paediatric rheumatology centre in the USA.

Xiaomeng YueBin HuangAna L HincapiePatricia R WigleYuxiang LiTingting QiuDaniel J LovellEsi M MorganJeff J Guo

Published in: Rheumatology (Oxford, England) (2021)

Persistence was significantly longer among patients initiating TNFi as their first biologic therapy than those receiving non-TNFi. Patients receiving TNF therapy had significant greater reduction of cJADAS at the 6-month follow-up visit compared with patients in the non-TNF cohort.

Keyphrases

juvenile idiopathic arthritis
rheumatoid arthritis
end stage renal disease
disease activity
newly diagnosed
ejection fraction
chronic kidney disease
intensive care unit
prognostic factors
peritoneal dialysis
stem cells
systemic lupus erythematosus
bone marrow
mesenchymal stem cells
cell therapy